GSK CEO: Drug pricing in the US needs to change, here's how
watch now

In this video

Share
Closing Bell

GSK CEO: Drug pricing in the US needs to change, here's how

Andrew Witty, GlaxoSmithKline CEO, discusses drug pricing in the United States, innovations in health care, & more.
07:26
Mon, May 2 20163:24 PM EDT

Kelly Evans